Clinical trial
Diagnostic Study of Performance of an Aspergillus Specific Polymerase Chain Reaction in Tissue and Pleural Effusion Samples of Immunocompromised Patients for the Diagnosis of Invasive Aspergillosis
NCT01902030 is registered in ClinicalTrials.gov with Heidelberg University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Diagnostic Study of Performance of an Aspergillus Specific Polymerase Chain Reaction in Tissue and Pleural Effusion Samples of Immunocompromised Patients for the Diagnosis of Invasive Aspergillosis
- Lead sponsor
- Heidelberg University
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- January 31, 2014
- Completion date
- December 31, 2020
- Enrollment
- 100 (estimated)
- Sites
- 12
Conditions
As the registry lists them; a condition with its own page is linked.
aspergillosis, immunosuppression